Heavy Early Morning Activity On GlaxoSmithKline (GSK)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified GlaxoSmithKline ( GSK) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified GlaxoSmithKline as such a stock due to the following factors:

  • GSK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $264.8 million.
  • GSK traded 713,823 shares today in the pre-market hours as of 8:25 AM, representing 12.6% of its average daily volume.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in GSK with the Ticky from Trade-Ideas. See the FREE profile for GSK NOW at Trade-Ideas

More details on GSK:

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The stock currently has a dividend yield of 5.6%. GSK has a PE ratio of 16.3. Currently there is 1 analyst that rates GlaxoSmithKline a buy, 1 analyst rates it a sell, and 6 rate it a hold.

The average volume for GlaxoSmithKline has been 3.9 million shares per day over the past 30 days. GlaxoSmithKline has a market cap of $113.7 billion and is part of the health care sector and drugs industry. Shares are down 12.6% year-to-date as of the close of trading on Tuesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

These Stocks Pay You to Own Them

Nascar Champ Danica Patrick--'I'm Not That Into Cars'

Nascar Driver Danica Patrick Says 'I'm Not a Car Person'

Hikma Sinks on Advair Generic Concerns

Shire Gains as it Seeks European Approval For Dry Eye Treatment